Clinical Trials

Our commitment has not only greatly contributed to the establishment of today’s gold standard therapy for choroidal neovascularization, but also backed numerous studies in the field of Ophthalmology and beyond. Over the last ten years, we have conducted clinical trials in the following areas: Dry and Neovascular Age Related Macular Degeneration, Diabetic Retinopathy and Diabetic Macular Edema, Retinal Vein Occlusion, Glaucoma, Epiretinal Membrane, Postoperative Therapy after Cataract Surgery, Pediatric Ophthalmology as well as ophthalmologic safety evaluations for treatments targeting malignant diseases of the skin, liver or bone marrow and autoimmune diseases of the nervous system.